...
机译:P1.08-034 eGFR突变在手术切除肺腺癌患者中的预后影响; 关于EGFR突变亚型的分析
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
General Thoracic Surgery Tokyo Medical University Hospital;
机译:P1.08-034 eGFR突变在手术切除肺腺癌患者中的预后影响; 关于EGFR突变亚型的分析
机译:P1.05-002手术切除肺癌患者EGFR突变状态和突变亚型的预后影响
机译:P1.05-002手术切除肺癌患者EGFR突变状态和突变亚型的预后影响
机译:肺腺癌的EGFR突变:与F-18 FDG PET / CT的相关性
机译:具有微卫星不稳定性的大肠癌患者的突变谱; BRCA2和EGFR体细胞突变的频率高
机译:完全切除的肺腺癌患者术前血清癌胚抗原水平与组织学亚型EGFR突变和ALK融合相关
机译:P1.08-034 eGFR突变在手术切除肺腺癌患者中的预后影响;关于EGFR突变亚型的分析